Cristina Mangas

Bellinzona, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Decision-Making in Intrathecal Therapy for Leptomeningeal Disease.

Journal: Oncology

Published: November 27, 2025

Pharmacy-based triage to preselect high-risk individuals for skin cancer screening: A pilot study.

Pharmacy-based triage to preselect high-risk individuals for skin cancer screening: A pilot study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 14, 2025

ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.

ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma.

Journal: Journal of clinical medicine

Published: November 14, 2025

The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

The updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma.

Journal: Swiss medical weekly

Published: August 14, 2025

Ultra-high Potency Topical Corticosteroids as a Potential Trigger for Reactive Perforating Collagenosis.

Ultra-high Potency Topical Corticosteroids as a Potential Trigger for Reactive Perforating Collagenosis.

Journal: Acta dermato-venereologica

Published: June 05, 2024

Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.

Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.

Journal: Acta dermato-venereologica

Published: November 20, 2023

Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.

Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: August 30, 2023

Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.

Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.

Journal: Journal of the American Academy of Dermatology

Published: July 06, 2023

Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Journal: American journal of clinical dermatology

Published: March 14, 2023

Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective study.

Similar local recurrence and survival in patients with T1 radial growth phase melanoma on head and neck treated with 5 or 10 mm margins: A retrospective study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 18, 2022

Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion.

Journal: American journal of clinical dermatology

Published: September 19, 2022

Reply to E. Hindié.

Reply to E. Hindié.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 24, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026